logo
Select company
Select metric
-133.86%Return on Equity
VS
Market
9
Sector
25
Industry
30
History
17
$ 6.18Close
$ 3 - $ 24 52-Week Range
Ticker Information

Ticker

GBIO

Company Name

GENERATION BIO CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GENERATION BIO CO - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GBIO - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 54.1M$ -72.42M-133.86%
3/31/2025$ 73.33M$ -71.93M-98.09%
12/31/2024$ 86.2M$ -131.67M-152.74%
9/30/2024$ 104.44M$ -145.47M-139.28%
6/30/2024$ 115.41M$ -158.43M-137.28%
3/31/2024$ 131.99M$ -169.06M-128.08%
12/31/2023$ 203.13M$ -126.61M-62.33%
9/30/2023$ 231.91M$ -123.83M-53.4%
6/30/2023$ 254.29M$ -126.87M-49.89%
3/31/2023$ 279.14M$ -133.73M-47.91%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GENERATION BIO CO's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, GENERATION BIO CO's average ROE has been -68.67%.
  • The median ROE for GENERATION BIO CO during this period was -48.37%
  • GENERATION BIO CO reached its highest ROE over the past 5 years at -19.26%.
  • The lowest ROE recorded by GENERATION BIO CO in the same timeframe -152.74%

GENERATION BIO CO's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
XLO : XILIO THERAPEUTICS INC -795.33%BCAB : BIOATLA INC -CRIS : CURIS INC -PRPO : PRECIPIO INC -14.66%MRSN : MERSANA THERAPEUTICS INC -DYAI : DYADIC INTERNATIONAL INC -XFOR : X4 PHARMACEUTICALS INC -2568.02%NEPH : NEPHROS INC 13.82%POCI : PRECISION OPTICS CORPORATION INC -47.15%NRXS : NEURAXIS INC -183.49%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for GENERATION BIO CO is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 286.54M ]
(=) ROE [ 0% ]

GBIO - Return on Equity, Last 5 years

-152.74%

Minimum

Dec 31, 2024

-19.26%

Maximum

Mar 31, 2021

-68.67%

Average

-48.37%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%